| J |
| J Oldenburg |
- |
Haemophilia A in a Women Caused By Swyer-Syndrom and a Missense Mutation in Factor VIII Gene |
| Jackowski R |
- |
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Stable Angina Pectoris Patients Undergoing Coronary Artery Bypass Grafting (CABG) |
| Jackson S |
- |
Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial |
| |
- |
Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH) |
| Jackson RD |
- |
Improved Oral Anticoagulant Therapy Monitoring by Eliminating ISI and MNPT from INR Determinations |
| Jackson CL |
- |
Development of a Mouse Serum Protein Map for Proteomic Research |
| Jackson DE |
- |
Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function |
| Jackson DE |
- |
The Ig-ITIM Superfamily Member, PECAM-1 Regulates the Outside-in Signalling Properties of Integrin aIIbb3 in Platelets |
| Jackson DE |
- |
Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function |
| Jackson DE |
- |
The Palmitolyated Cysteine 595 Residue of PECAM-1 Is Required for Constitutive Association of PECAM-1 into Membrane Microdomains |
| Jackson SP |
- |
Distinct Roles for the Type I PI 3-Kinases, p110b and p110g, in ADP-Stimulated Platelet Activation |
| Jackson C |
- |
Thrombin Inhibition with Melagatran Prevents Plaque Rupture in Apolipoprotein E Knockout Mice |
| Jackson SP |
- |
Conversion of Platelets from a Pro-Aggregatory to Pro-Inflammatory Adhesive Phenotype: A Role for PAF in Spatial Neutrophil Activation on Thrombi |
| Jackson S |
- |
Shear-dependent Role for Soluble P-selectin in Regulating Neutrophil Adhesion to Platelets |
| Jackson SP |
- |
Specific Role of the GPVI/FcRg Complex in Promoting Thrombus Formation Following Superficial But Not Deep Arterial Injury |
| Jacob L |
- |
Evaluation of Stability of Sucrose Formulated, Full-Length Rfviii for Use in Continuous Infusion Therapy |
| Jacobs R |
- |
Thromboembolic and Bleeding Complications during Non-cardiac Surgery in Patients with Mechanical Heart Valves |
| Jacobs N |
- |
Malaria Infection Induced Thrombocytopenia Is not Related to Systemic Platelet Activation |
| Jacobs LG |
- |
Anticoagulation for Patients with Inferior Vena Cava Filters |
| Jacobs DR |
- |
Dietary Vitamin B6 and Folate Intake is Inversely Related to Risk of Developing Venous Thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE) |
| Jacobs M |
- |
Precursors of Novel Gla-Containing Conotoxins Contain a Carboxy-Terminal Recognition Site that Directs g-Carboxylation by g-Glutamyl Carboxylase |
| Jacobson A |
- |
Independent Qa Exercise to Validate Poc Coagulometer Reliability in Support of the Thinrs Trial and to Allay Perceptions of Possible Coagulometer Dysfunction |
| |
- |
Effective Anticoagulation Self-Management in a Diverse Population of Oral Anticoagulation Patients Using the Protime System |
| |
- |
Low-Molecular-Weight Heparin or Unfractionated Heparin as Bridging Therapy in Patients on Long-term Oral Anticoagulants: Results from the REGIMEN Registry |
| |
- |
Independent QA Exercise to Validate INR Test Strip Performance and Evaluate Perceptions of Excess Test Strip Error Messages in Support of the THINRS Trial |
| Jacobson A |
- |
Demonstration of Patient Ability to Maintain Long Term Competence Equivalent to Professionals, Utilizing the HemoSense® INRatio® System for Home INR Testing |
| Jacobson BF |
- |
Pilot Study: Aspirin Resistance and/or Platelet Hypersensitivity in Cerebrovascular Disease |
| Jacobson L |
- |
Clinical Application of the Clot Formation and Lysis (ClofAL) Assay to Physiologic and Pathologic Changes in Factor VIII |
| Jacobson A |
- |
Utility and Multi-site Acceptance of Patient Self-Reporting of INR Self-Test Results to a Central Database Utilizing a Computerized Interactive Voice Response System in the THINRS Study |
| Jacobsson EG |
- |
The Effect of Platelets on Fibrin Gel Structure Formed in the Presence of Recombinant Factor VIIa in Haemophilia Plasma and in Plasma From a Patient with Glanzmann Thrombasthenia |
| Jacobsson A |
- |
A Single Preoperative dose of Tranexamic Acid Reduces Blood Loss and Heterologous Blood Transfusion in Radical Retropubic Prostatectomy |
| Jacoby R |
- |
Absolute CD62 Expression and PAC-1 Binding Correlate with Decreased PFA-100 Closure Times Seen in Severely Injured Patients |
| Jacquemin M |
- |
Antigen Binding Site Glycosylation Determines the Anticoagulant Activity of a Type II Factor VIII Antibody without Modifying Affinity or Epitope Specificity |
| |
- |
Mapping of B Cell Epitopes on the Factor VIII C2 Domain |
| |
- |
Anti-idiotypic Monoclonal Antibodies (Anti-Id mabs) Neutralizing Anti-FVIII Antibodies (abs) Directed Towards Heavy and Light Chains Fully Protect FVIII Function |
| |
- |
Antibody to C1 Domain of Factor VIII Alters Interaction of Factor Xase Complex with Factor X |
| Jacques Michiels J |
- |
Pretreatment with Aspirin and Loading Dose Clopidogrel Obviates the Need for Glycoprotein Iib/Iiia Antagonists During Elective Coronary Stenting |
| Jacques Michiels J |
- |
Non-Invasive Diagnosis of Pulmonary Embolism Anno 2005 |
| Jadaon MM |
- |
Factor V Kuwait: a New Point Mutation in the Coagulation Factor V Gene |
| |
- |
The Risk of Venous Thrombosis Increases with Co-existence of Multiple Genetic Abnormalities: A Comprehensive Study in Kuwait |
| Jaeckel J |
- |
In vitro Determination of Platelet Function in Whole Blood from Obese Children and Adolescents |
| Jaeken J |
- |
Loss of Gs Activity in Platelets from Carriers with a Heterozygous Missense Mutation in the Regulator of G-protein Signaling 2 (RGS2) |
| Jaffer AK |
- |
The Perioperative and Periprocedural Management of Warfarin: The PPMW Study |
| Jahnen-Dechent W |
- |
Enhanced Blood Coagulation and Fibrinolysis in Mice Lacking Histidine-Rich Glycoprotein/HRG |
| Jain R |
- |
Unusual Thrombophilic Manifestations of Protein C Deficiency, Factor V Leiden and Antiphospholipid Syndrome From Sultanate of Oman |
| Jaiprakash M |
- |
Gene Conversions Are a Common Cause of von Willebrand Disease |
| Jairajpuri MA |
- |
Cofactor Binding Dependent Hydrogen Bond Formation between Antithrombin III Strand 3A Tyrosine-220 and Strand 5A Glutamic Acid 374 Is Necessary for Backwards Conformational Adjustments Leading to Fully Developed Ionic Interactions between the Pentasaccharide and ATIII, and for Stabilization of High Affinity Heparin Binding |
| Jairajpuri MA |
- |
Disruption of a Hydrophobic Cluster Surrounding Tyearosine-131 in the Native Conformation of Antithrombin III Activates it for Factor Xa Inhibition and Increases Its Affinity for Heparin |
| Jakiela B |
- |
Anti-thrombotic Action of Clopidogrel is More Pronounced in Patients with Coronary Artery Disease Carrying PlA2 Allele of Beta3 Integrin |
| Jakovljevic V |
- |
Platelets/Endothelium Interaction and Oxidative Stress in Isolated Guinea-Pig Heart: Focus on L-Arginine/ No System and Superoxide Anion Radical Production |
| Jakubowski JA |
- |
Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects |
| |
- |
CS-747 (Prasugrel, LY640315), a Novel Antiplatelet Agent, Inhibits Arterial Thrombosis Through Selective Blockade of Platelet P2Y12 Receptors |
| |
- |
Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel Show Similar in vitro P2Y12 Receptor Blockade But Greater in vivo Potency of CS-747 |
| |
- |
CS-747 (Prasugrel, LY640315) Produces Potent and Sustained Platelet Inhibitory Effects in Dogs and Monkeys During Multiple Dosing That Are Enhanced by Co-administration of Aspirin |
| |
- |
Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation |
| Jakubowski JA |
- |
Comparative Antiplatelet Effects of the Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel |
| Jakubowski JA |
- |
Effective Inhibition of Platelet Aggregation and Release Reaction with Lack of Effect on Shape Change by CS-747 (Prasugrel, LY640315) and Its Active Metabolite |
| Jakunina L |
- |
The State of Fibrinolytic and Coagulation Systems in Hemophiliacs |
| Jalagadugula G |
- |
Transcriptional Regulatory Elements in the 5'-Upstream Region of Gaq Gene in a Human Megakaryocytic Cell Line |
| Jalali F |
- |
Risk Factor Assessment in the Management of Patients with Suspected Deep Venous Thrombosis |
| |
- |
Venous Function and Clinical Outcome Following Deep Vein Thrombosis |
| James PD |
- |
The Mutational Spectrum of Type 1 Von Willebrand Disease (VWD): Results from the Canadian Type 1 VWD Study |
| James PD |
- |
A Case of Non-Resolving Hemophilia B Leyden in a 40 year Old Male (Factor IX promoter +13 A to G) |
| James PD |
- |
Understanding the Genotype/Phenotype Link in Type 1 von Willebrand Disease (VWD): Results from The Canadian Type 1 VWD Study |
| James A |
- |
Pregnancy-Related Arterial and Venous Thromboembolism in the United States 20002001 |
| Jaminet P |
- |
Polymorphisms Known to Increase the Risk of Atherothrombosis Do Not Affect the Risk of Thrombembolism as Determined in Patients with Atrial Fibrillation |
| |
- |
A Unique Fusion Protein Combines Clot Targeting, Platelet Blockade and Direct Factor Xa Inhibition in One Molecule |
| Jamison M |
- |
Pregnancy-Related Arterial and Venous Thromboembolism in the United States 20002001 |
| Jan R |
- |
Protein S Multimers are Generated in vitro and do Not Bind to C4b-binding Protein: Implications for Protein S Structure-Function Analysis |
| Jan TR |
- |
Lactadherin Detects and Blocks Phosphatidylserine in vivo on Stimulated Platelets |
| Janatpour KA |
- |
Prevalence and Clinical Utility of IgA Isotype Antiphospholipid Antibodies |
| Janatpour K |
- |
Absolute CD62 Expression and PAC-1 Binding Correlate with Decreased PFA-100 Closure Times Seen in Severely Injured Patients |
| Janatpur K |
- |
Evaluation of the Warkentin 4 T's Clinical Prediction Tool for Heparin-Induced Thrombocytopenia (HIT): Comparison to the Chong's HIT Classification Score |
| Jandrot-Perrus M |
- |
Modulation of Protease Nexin-1 Activity by Polysaccharides |
| |
- |
Glycoprotein VI Structure-Function Relationship: Identification of Collagen Binding Domains Using GPVI/FcaR Chimera |
| |
- |
Integrin a2b1 and Glycoprotein VI Dependent Calcium Signals in Platelets Interacting with Acid-Soluble Type I Collagen Under Flow |
| |
- |
Crosstalk Between Integrins a2b1 and aIIbb3 during Platelet Activation |
| Jane S |
- |
Effects of G-CSF/SCF on Cardiac Function and Cellular Repair Processes after Acute Myocardial Infarction |
| Jang SS |
- |
IgM Anti-beta2 Glycoprotein I Antibody as Potential Risk Factor of Thrombosis in Patients with Lupus Anticoagulants |
| Jankovicova D |
- |
Gynaecological Problems in Severe Congenital Factor VII Deficiency |
| Jankowski M |
- |
Molar Specific Activity of Factor VIII: An Alternative Means of Comparing FVIII Concentrates |
| |
- |
Comparative Structural Analysis of Recombinant Factor VIII (rFVIII): Defining Full-Length FVIII |
| Jansen M |
- |
Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation |
| Janson T |
- |
Afinion AS100 Analyzer a Multi-Assay System Including a New PT-INR Test |
| Janssen M |
- |
Laboratory and Clinical Validation of a New Functional, Plasma-Based Assay for the Detection of Factor V Leiden: the Pefakit® APC-R Factor V Leiden Assay |
| Janssen HLA |
- |
Highly Elevated Levels of Von Willebrand Factor in Patients with Liver Cirrhosis Support Platelet Adhesion Despite Its Reduced Functional Capacity |
| Jansson L |
- |
Human Aortic Endothelial Cells Inhibit Thrombin Generation in vitro and Augment Inhibition by Melagatran |
| Janz K |
- |
A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation |
| |
- |
WAY-197697, a P-selectin Antagonist, Reduces Atherosclerosis in Apolipoprotein E Deficient Mice |
| Jardine L |
- |
Immune Tolerance to Factor IX inhibitor |
| Jarvis GE |
- |
GPVI-Dependent Binding of Murine Platelets to a Series of Triple-Helical Peptides Derived from Human Type III Collagen |
| Jaskolowski S |
- |
An Evaluation of the New ACL TOP Coagulation Autoanalyser |
| Jason Y |
- |
The VASP Index: A New Reliable Method to Detect Response Variability after Clopidogrel |
| |
- |
High Platelet Reactivity is a Risk Factor for Post-Discharge Ischemic Complications Following Elective Coronary Stenting |
| |
- |
A New Method to Measure P2Y12 Receptor Expression on the Surface of Human Platelets: Effect of Clopidogrel |
| Jatene FB |
- |
Intraoperative Automatic Autotransfusion for Lung Transplantation |
| Javen D |
- |
Comparison of Four D-Dimer Tests Combined with Clinical Probability Assessment to Exclude Deep Venous Thrombosis in Symptomatic Outpatients |
| Jayandharan G |
- |
Molecular Characterization of Haemophilia B: 17 Novel Mutations in Patients of Indian Origin |
| Jayasuriya K |
- |
Effect of Mechanical Ventilation on the Hemostatic State of the Newborn |
| Jazebi H |
- |
High Sensitivity of Monochloroacetic Acid 1% Clot Lysis Test for Diagnosis of Severe FXIII Deficiency |
| Jazebi M |
- |
Mutation Analysis of the Factor VIII Gene in 224 Iranian Families with Haemophilia A |
| Jeimy SB |
- |
Identification of the Multimerin 1 Binding Region within the C1 Domain of Factor V |
| Jenkins A |
- |
Associations of Inflammatory and Haemostatic Variables with the Risk of Recurrent Stroke |
| Jennings GM |
- |
Haemostatic and Haemodynamic Responses to Different Intermittent Pneumatic Compression (IPC) Protocols used for Prophylaxis against Deep Venous Thrombosis (DVT) |
| Jennings I |
- |
Preparation of Reference Materials for the Genetic Diagnosis of Thrombophilia |
| |
- |
The SSC/ISTH Secondary Coagulation Standard in UK NEQAS for Blood Coagulation Proficiency Testing Exercises: Assigned Values for FV:C and FXI:C Should Assist in the Standardisation of These Assays |
| Jennings GM |
- |
Clinical Measurements of Platelet Activation by Flow Cytometry Under Optimised Conditions |
| Jennings LK |
- |
Regulation of CD154 (CD40L) and CD62 (p-selectin) Cell Surface Density May Be a Critical Mechanism in Conferring Proinflammatory and Prothrombotic Effects |
| Jennings I |
- |
Comparison of Coaguchek S INRa with Hospital Laboratory Citrated Plasma INRs What Is the Truth? |
| |
- |
A Need for Standardisation in D-Dimer Testing: Evidence from a Collaborative Study by the UK NEQAS and QMP-LS Quality Assessment Programmes |
| Jennings GM |
- |
Endothelial and Platelet Function in Healthy Human Volunteers Treated with Pregabalin: Implications for the Development of Haemangiosarcoma Seen in Mice |
| Jerczynska H |
- |
Thalidomide Affects Early Phases of VEGF Stimulated Angiogenesis in Human Endothelial Cells |
| Jern S |
- |
Proinflammatory Cytokines Impair Endothelial Fibrinolytic Capacity Partly Independently of NFkB |
| Jern C |
- |
C-reactive Protein Polymorphisms and Ischemic Stroke |
| |
- |
Fibrinolytic Gene Polymorphism and Ischemic Stroke |
| Jeske W |
- |
Proteomic Profiles in Critically Ill Emergency Department Patients, Utilizing ProteinChip Array Technology |
| Jeske WP |
- |
Effect of 1,6-Anhydro Bicyclic Ring Structure on the Pharmacokinetic and Pharmacodynamic Behavior of Low Molecular Weight Heparin |
| Jeske WP |
- |
Fish Skins as a Source of Heparin-Like GAGs |
| Jeske WP |
- |
Biochemical and Pharmacological Equivalence of Generic Versions of Low Molecular Weight Heparins. A Comparative Study with Innovator Products |
| Jeske J |
- |
Argatroban Interactions with Low Molecular Weight Heparins: Pharmacologic Implications |
| Jeske WP |
- |
Differential Digestion of LMWHs By Heparinase-I and Heparinase-II: Drug Developmental Implications |
| Jeske J |
- |
Cross Validation of the 2nd International Standard of Low Molecular Weight Heparin (IS 200301/608) in the Anti-Xa, Anti-Iia Heptest and PiCT Tests |
| Jeske WP |
- |
Hyperhomocysteinemia in Cancer Patients with Thrombosis Is Not Associated with Methylene Tetrahydrofolate Reductase (MTHFR) Gene Mutations and Can Be Down Regulated by Low Molecular Weight Heparin Treatment |
| |
- |
Enoxaparin (E) and Warfarin (W) Differentially Regulate Tissue Factor (TF), Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activatable Fibrinolytic Inhibitor (TAFI) in Cancer Patients with Thrombosis |
| Jeske WP |
- |
Platelet and Inflammatory Alterations Associated with Late Restenosis in Patients Undergoing Angioplasty and Brachytherapy |
| Jeske WP |
- |
Novel Dual-Action Anti-Platelet/Anti-Thrombotic Drugs for the Management of HIT |
| |
- |
Consideration of HIT Antibody Isotype in Interpretation of the Serotonin Release Assay |
| Jeske W |
- |
Elevated Nitric Oxide Levels with Brachytherapy Compared to Bare Metal or Sirolimus Eluting Stents. Implications in Coronary Restenosis |
| Jeske WP |
- |
Arresting Platelet Activation Induced by HIT Antibodies Using a Desulfated Heparin |
| Jesmok G |
- |
Cross-Species Pharmacologic Evaluation of Plasmin as a Direct-Acting Thrombolytic Agent: ex vivo Evaluation for Large Animal Model Development |
| |
- |
Supplemental Alpha-2-Antiplasmin Prevents Plasmin-Induced Hemorrhage |
| |
- |
Increased Sensitivity for Measurement of Factor VIII Using ROTEG and FVIII-/- Mouse Blood Supplemented with rFVIII |
| Jespersen J |
- |
Reduced Fibrin Compaction and Increased Fibrin Formation Rate in Patients with End-Stage Renal Disease |
| |
- |
Occurrence of Venous Thrombosis (VT) Is Not Increased in Women Taking Postmenopausal Hormonal Replacement Therapy (HRT) in the Danish Osteoporosis Prevention Study (DOPS) |
| Jessup W |
- |
Serum Amyloid A (SAA) Induces Monocyte Tissue Factor |
| Ji Q |
- |
Contrast Medium Attenuates Platelet Activation and Platelet-Leukocyte Cross-Talk |
| Ji X |
- |
Treatment with Gelatin Absorbed Clodronate in the Management of Immune Thrombocytopenic Purpura in a Rat Model |
| Ji S |
- |
A Monoclonal Antibody Against Platelet GPVI Impaires the Interaction Between Platelet and Collagen |
| |
- |
Imaging Experimental Pulmonary Embolism in Dogs Using 99mTc-Llabeled SZ51-F(ab)2 |
| Ji Q |
- |
Effects of Acute Hyperglycaemia on Platelet and Leukocyte Activation: Involvement of Multiple Mechanisms |
| |
- |
Platelet-Lymphocyte Conjugation: Different Behavior Between T and B Cells |
| Jialan S |
- |
Lactadherin Detects and Blocks Phosphatidylserine in vivo on Stimulated Platelets |
| Jiang X |
- |
Treatment with Gelatin Absorbed Clodronate in the Management of Immune Thrombocytopenic Purpura in a Rat Model |
| Jiang F |
- |
Nitric Oxide Modulates NADPH Oxidase Function through Haemoxygenase-1 Induction in Human Endothelial Cells |
| Jiang S |
- |
Acquired Risk Factors Play a Major Role in Venous Thrombosis in Chinese Population |
| Jiang L |
- |
A Mechanism of Impaired Platelet Response to ADP Stimulation in the CLIC1 Knockout Mice |
| Jiang X-C |
- |
Evidence of a Critical Role for F11R (a.k.a. JAM-1) in the Adhesion of Platelets to the Endothelium at the Onset of Inflammatory Thrombosis |
| Jiao YK |
- |
Imaging of Highly Organized Vitronectin-Vimentin Polymeric Complexes that Express on the Surface of Activated Platelets and Platelet Microparticles using Atomic Force Microscopy |
| Jie QZ |
- |
The Expression of Recombinant Adeno-Associated Virus/Human Coagulant Factor IX Gene in Human/Rat Gut Epithelial Cells |
| Jie AFH |
- |
Development of a New Test for the Global Fibrinolytic Capacity in Blood |
| Jilma B |
- |
Effects of the Pan-Selectin Antagonist Bimosiamose (TBC1269) on LPS Induced Coagulation |
| |
- |
The Effects of Supra-Normal Protein C Levels on Markers of Coagulation, Fibrinolysis and Inflammation in a Human Model of Endotoxemia |
| |
- |
Anticoagulant and Anti-inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge |
| Jilma B |
- |
Platelet Hyperfunction and Low Response to Aspirin Predict Re-events in Patients With Acute Coronary Syndromes During Long Term Follow Up |
| Jilma B |
- |
Plasma Proteomics in Human Endotoxemia: A Novel Approach Using MALDI-TOF Profiling and iTRAQ Labeling Reveals Oxidation Of Plasma Proteins and Other Significant Changes |
| Jimenez V |
- |
Surgery in Haemophilic Patients with Inhibitor |
| |
- |
Polipectomia in a Patient with a Moderate Congenital Deficiency of Factor V |
| Jiménez JJ |
- |
Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions |
| Jin YR |
- |
The Antiplatelet Activity of Hesperetin Is Mainly Mediated By Inhibition of PLCg2 Phosphorylation and Its Downstream Signal Transduction |
| Jin J |
- |
Activation of G12/13 Pathway is Essential for the Dense Granule Release in Platelets |
| Jin YR |
- |
Inhibitory Effect of Luteolin on the PDGF-Induced Proliferation of Rat Aortic Vascular Smooth Muscle Cells |
| Jin Z |
- |
Lactadherin Detects and Blocks Phosphatidylserine in vivo on Stimulated Platelets |
| Jin J |
- |
Molecular Mechanism and Functional Implications of Thrombin-Mediated Tyrosine Phosphorylation of PKCd in Platelets |
| Jin W |
- |
Development of ADP-coated Bead Columns for Ticlopidine Monitoring |
| Jin J |
- |
G12/13 Pathways Potentiate Akt Phosphorylation Mediated by Gi/Gz Pathways in Platelets |
| |
- |
Identification of Two Novel Mutations in ADAMTS13 Gene in A Pregnant Patient with Congenital Thrombotic Thrombocytopenic Purpura |
| Jinga V |
- |
Cardiomyogenic Differentiation Induced by in vitro Manipulation of Adult Stem Cells |
| Jinoch P |
- |
A Multicentre Study on 50 Cases with Thrombotic Thrombocytopenic Purpura in the Czech Republic: Recurrent Mutation in ADAMTS13 Gene as a Cause of a Hereditary Thrombotic Thrombocytopenic Purpura |
| JMenitove J |
- |
Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels |
| Jobe SM |
- |
Oxidant Signaling as a Mediator of Platelet Procoagulant Activity and Coated Platelet Formation |
| Johansen P |
- |
Visualization of Dynamic Fibrin Formation from APTT Recordings Reflects More Heterogeneity in Patients with Severe Haemophilia A Than Conventional APTT Values |
| |
- |
Visualization of the Continuous APTT Coagulation Signature Methods and Correlations to Continuous Thrombin Generation |
| Johanson S |
- |
The Accuracy of the Wells Pretest Probability Assessment Model for Proximal Deep Vein Thrombosis When Applied by Emergency Department Doctors in South Australia |
| |
- |
Accuracy of a Whole Blood D-Dimer Assay (SimplifyTM) for Deep Vein Thrombosis, When Performed Using Venous Whole Blood and Frozen Plasma in a Cohort Patients with Suspected Deep Vein Thrombosis |
| Johansson M-C |
- |
Inhibition of the Renin-Angiotensin System Does Not Reduce Platelet Activity at Rest or during Stress in Essential Hypertension |
| Johansson P |
- |
Platelet Activation and Interaction of rFVIIa (NovoSeven®) with COAT Platelets Following Cardiopulmonary Bypass |
| Johansson AM |
- |
Large Deletions Explain Protein S Deficiency in Many Cases Where Previous Mutation Detection Has Failed |
| Johansson U |
- |
Composite Islet-Endothelial Cell Grafts: A Novel Approach to Counteract Innate Immunity in Islet Transplantation |
| Johansson MC |
- |
Effects of Oral Hormone Replacement Therapy (HRT) on Platelet Function, Inflammatory Markers and Matrix Metalloproteinases in Postmenopausal Women with Established Coronary Artery Disease |
| Johansson M-C |
- |
Effects of Improved Metabolic Control on Platelet Reactivity in Patients with Type 2 Diabetes Mellitus Following Coronary Angioplasty |
| |
- |
Food Intake Enhances Platelet Reactivity to Thromboxane in Type 2 Diabetic Patients |
| Johansson AM |
- |
Genetic Variation of VWD Type I in Sweden: Tracing the Evolutionary History of the von Willebrand Factor Gene Region |
| Johansson PI |
- |
FVIIa Decreases Surgery-Induced IL-6 Response in Burn Patients Undergoing Excision and Skin Grafting |
| Johansson M-C |
- |
Contrast Medium Attenuates Platelet Activation and Platelet-Leukocyte Cross-Talk |
| Johansson AM |
- |
Co-segregation of the PROS1 Locus and Protein S Deficiency in Families having no Detectable Mutations in PROS1 |
| Johansson M-C |
- |
Postprandial Hyperglycaemia Induces Platelet Activation in Type 2 Diabetes Mellitus: Effects of Treatment with Repaglinide and Glibenclamide |
| Johansson AM |
- |
The Haplotype Structure of the von Willebrand Factor (VWF) Gene Promoter Indicates Balancing Selection |
| Johansson H |
- |
Tissue Factor Is Associated with a Negative Outcome of Clinical Islet Transplantation |
| Johnell M |
- |
Activation of MAP Kinase Pathway in Monocytes by TF/FVIIa is Required for TNF-a Production but not for PDGF-BB Induced Chemotaxis |
| Johnsen J |
- |
An Endothelial Cell-specific Regulatory Mutation In Galgt2 Is the Major Cause of Prolonged aPTT in Mice |
| Johnson BD |
- |
Modulating Murine Platelet Function by Expressing Integrin aIIbb3 Locked-In Its High Affinity State |
| |
- |
Murine Hemophilia A is Phenotypically Corrected by Platelet-Expressed Factor VIII Even in the Absence of Detectable Plasma FVIII |
| Johnson A |
- |
Raised Blood Leukocyte Counts Markedly Alter Platelet Aggregation Extent induced by ADP and ATP via CD39 |
| Johnson C |
- |
The Use of Recombinant Factor VIIa (rFVIIa) for the Treatment and Prevention of Excessive Bleeding in Non-Hemophiliac Children |
| Johnson WD |
- |
Highly Sensitive and Specific Test Panel Results in an Improved Laboratory Diagnosis of the Lupus Anticoagulant 19982004 |
| Johnson A |
- |
Contributions of Blood Cells to Adenine Nucleotide Metabolism |
| Johnson J |
- |
Residual Anticoagulant Activity Following Bridging Low Molecular Weight Heparin: Prevalence and Risk Factors |
| |
- |
Gene Targeting or Pharmacological Inhibition of Rac GTPases Prolongs the Bleeding Time and Reduces Platelet Adhesion, Secretion and Aggregation: Evidence for the Rac-Mediated Activation of MAP Kinases during Platelet Activation |
| Johnson FL |
- |
Phase 1 Pharmacokinetic, Pharmacodynamic, and Safety Evaluation of a Novel Rapidly Reversible Intravenous Platelet P2Y12 ADP Receptor Antagonist, INS50589 |
| Johnson J |
- |
Predictors of Mid-interval Low Molecular Weight Heparin Anti-Xa Levels |
| Johnson GJ |
- |
Platelet Shape Change Stimulated by Low Concentration TP Receptor Agonist Is Independent of p38 MAP Kinase Pathway Activation But Requires Myosin Activation |
| Johnston N |
- |
Gender Related Differences in Coagulation Activity in Unstable Coronary Artery Disease Patients and Apparently Healthy Individuals |
| Johnston L |
- |
Optimising Anticoagulant Management Strategies through the Use of Validated Educational Interventions |
| Johnston N |
- |
Higher Coagulation Activity and anti-Xa levels During Dalteparin Treatment in Women with Unstable Coronary Artery Disease |
| |
- |
The Impact of Tissue Factor Single Nucleotide Polymorphisms on Risk, Outcome and Plasma levels in Acute Coronary Syndrome |
| Johnston A |
- |
Use of a Functional Assay to Diagnose Protein S Deficiency; Increasing Testing of Obstetric Patients Yields Unreliable Results |
| Johnston M |
- |
Effect of Sample Collection Conditions on Interleukin-18, Serum Amyloid A and Monocyte Chemo-Attractant Protein-1 ELISA Measurement in Human Serum |
| |
- |
Fibrinolytic Activity Is Enhanced after Major Orthopedic Surgery |
| Johnston M |
- |
Long Term Storage and Stability of Urinary 11-Dehydro Thromboxane B2 |
| Johnston M |
- |
Evaluation of the Relationship between Free Protein S Levels and Thrombin Generation during Pregnancy |
| Johnston M |
- |
Calculation of the Direct INR Calibration Line Using Linear and Orthogonal Regression |
| Johnston A |
- |
Combining Pretest Probability Score and Antigenic Assays in the Diagnosis of HIT A Viable Alternative to Functional Assays |
| Johnston K |
- |
Prothrombin Fragment 1 and Annexin V Localize Differently after Laser Induced Vascular Injury in vivo |
| Johnstone BR |
- |
Brachial Artery Thrombosis in Infants: A Multidisciplinary Algorithm for Limb Salvage |
| Jolicoeur MEBérubéC |
- |
Use of D-Dimer (DD) in The Management of Suspected Deep Venous Thrombosis and Pulmonary Embolism in the Emergency Room: Prospective Observations Over 1 year |
| Jones DW |
- |
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) has Different Effects on Fibrinolysis Induced by Tissue-Type Plasminogen Activator (t-PA) and Urokinase-Type Plasminogen Activator (u-PA) in a Whole Blood Thromboelastography Model |
| Jones RM |
- |
Massive Sinus Thrombosis in a Six-Year-Old Girl: Acute Management and Identification of a Possible New Hypercoagulable State |
| Jones DW |
- |
The Effect of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) on Tissue-Type Plasminogen Activator (t-PA) and Urokinase-Type Plasminogen Activator (u-PA) Induced Fibrinolysis in a Plasma Clot Lysis Assay |
| |
- |
Case Report of Patient with Homozygous FXII deficiency, Heterozygous FXI deficiency and Antiphospholipid Antibodies |
| |
- |
The Effect of Corn Trypsin Inhibitor on Whole Blood Thrombin and Thrombus Generation Parameters |
| Jones CI |
- |
Hypobaric Hypoxia Reduces Thrombus Formation Rate Measured by Thromboelastography |
| Jones DW |
- |
Evaluation of Fluorogenic Substrates for the Monitoring of Thrombin Generation |
| Jones T |
- |
Venous Thromboembolism after Spinal Cord Injury: Incidence, Time Course and Associated Risk Factors in 6240 Adults and Children |
| Jones CI |
- |
Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation |
| Jones JE |
- |
Successful Use of FEIBA to Control Postoperative Bleeding after Use of rFVIIa |
| Jones DW |
- |
Whole Blood and Plasma Thrombus Generation Derived from Thromboelastography as an Alternative to Endogenous Thrombin Potential |
| Jones CI |
- |
Metabolism of Arachidonic Acid through 12-LOX in Platelets May Account for Transient Aspirin Resistance Linked to Treatment with Heparin |
| Jones C |
- |
Tissue Factor Pathway Inhibitor (TFPI) Contributes to the Early Anticoagulant Effect of Unfractionated Heparin (UFH) during Haemodialysis |
| Jones S |
- |
Platelets Act as Targets for Newly Identified Peripheral Tachykinins |
| Jones C |
- |
Heparin Monitoring During Haemodialysis in Children |
| Jones G |
- |
Validation of Overt Disseminated Intravascular Coagulation (DIC) Scoring Algorithm Use in Critically Ill Patients: Correlation with Inflammatory Markers and APACHE and SOFA Scores |
| Jones CD |
- |
Identification and Molecular Characterization of a Novel Factor V A2 Domain Tyrosine Deletion Mutation in a Patient with Factor V Deficiency and Bleeding |
| Jong G-P |
- |
Elevated Plasma Levels of High Sensitivity C-Reactive Protein in Patients with Coronary Bridge and No Significant Coronary Stenosis |
| Jonson B |
- |
Home Treatment in Pulmonary Embolism |
| Joø GB |
- |
Lipopolysaccharide-induced Monocyte Procoagulant Activity Discrepancy Between Tissue Factor Activity and Tissue Factor Expression May Reside in Increased Phosphatidylserine Exposure Due to Cell Death |
| Jood K |
- |
C-reactive Protein Polymorphisms and Ischemic Stroke |
| |
- |
Fibrinolytic Gene Polymorphism and Ischemic Stroke |
| Joop K |
- |
Pravastatin Reduces Levels of the Glycoprotein IIIa Subunit from the Fibrinogen Receptor on Platelet-Derived Microparticles in Patients with Type 2 Diabetes |
| Joosen AMCP |
- |
The Thrombogram in Twins, Influence of Oral Contraceptive and Intercurrent Infection |
| Jordan R |
- |
Neonatal DIC by Enterovirus. Favorable Outcome with Maternal Plasma Transfusion |
| Jordi F |
- |
Effect of F7 Gene Promoter Polymorphisms on Factor VII Antigenic Levels |
| JorfeldtLärfars LG |
- |
The Expression of von Willebrand Factor Antigen Differ Between Deep Vein Thrombosis and Pulmonary Embolism |
| Jörg I |
- |
Follow-Up of Patients with Acute Venous Thromboembolism Treated with Ximelagatran for Prophylaxis of Recurrent Events |
| Jorge DP |
- |
Role of FcRg and FXIII in Coated Platelet Formation and Platelet Procoagulant Activity in Mice |
| Jorgensen LN |
- |
Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis Against Venous Thromboembolism in Patients after Cancer Operations: A Meta-Analysis |
| Jorgensen LN |
- |
Prolonged Thromboprophylaxis with Dalteparin May Improve Survival in Patients Operated on for Abdominal Cancer |
| Jorquera JI |
- |
A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates |
| Joseph JE |
- |
Prothrombotic Potential of Sclerosants: In Vitro Effects on Coagulation, Red cells and Platelets |
| Joseph J |
- |
Diagnostic Dilemma of a Patient with Strong Lupus Anticoagulant and Intramuscular Haemorrhage, Requiring Treatment with Recombinant FVIIa |
| Joseph JE |
- |
Methodological Issues Which May Influence the Detection, Quantitation and Functional Assessment of Platelet-Derived Microparticles |
| |
- |
The Activation of Intracoronary Monocytes and Platelets Correlates with Cardiac Enzyme Levels in Patients Undergoing Coronary Artery Stenting |
| Joseph J |
- |
Comparison of Four D-Dimer Tests Combined with Clinical Probability Assessment to Exclude Deep Venous Thrombosis in Symptomatic Outpatients |
| |
- |
A Mechanism of Impaired Platelet Response to ADP Stimulation in the CLIC1 Knockout Mice |
| Joseph JE |
- |
A Minor Variation of the APTT Mixing Test Can Be Used to Identify Defects in the Contact Mechanism |
| |
- |
Procoagulant Phospholipid Activity Associates Not Only with Free Microparticles, But with Platelets and/or Microparticles Complexed to Erythrocytes and Leukocytes |
| Joseph J |
- |
Combining Pretest Probability Score and Antigenic Assays in the Diagnosis of HIT A Viable Alternative to Functional Assays |
| Joshi AV |
- |
Cost-Effectiveness of Different Treatment Regimens Consisting of NovoSeven® Versus FEIBA VH for the Home Treatment of Minor-to-Moderate Bleeds in Hemophilia Patients With Inhibitors in the United States: A Cost-of-Bleed Model |
| Joshi S |
- |
Plasma Homocysteine and Coronary Artery Disease (CAD) in Asian Indians: An Unlikely Risk Factor |
| Joshua D |
- |
The Lupus Ratio Test for Detection of Lupus Anticoagulants: Evaluation of Two Fully Automated aPTT-based Procedures That Use Commercially Available Reagents |
| Journeycake JM |
- |
Management of Asymptomatic Catheter-related Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): A Survey of Clinical Practice |
| Joutsi-Korhonen L |
- |
Surfaces of Glycoprotein VI Involved in Collagen Binding and Receptor Clustering |
| Joutsi-Korhonen L |
- |
Platelet Function Analyzer (PFA-100R) Detects Intranasal Desmopressin Responses in Patients with Hemophilia A and von Willebrand Disease |
| Jover S |
- |
Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution |
| Joyal F |
- |
The VEINES-QOL/Sym Questionnaire Is a Valid and Reliable Measure of Quality of Life in Patients with Deep Venous Thrombosis |
| Jr, Wojtukiewicz MZ |
- |
Immunohistochemical Localization of Protein Z (ZP) and Protein Z-Dependent Protease Inhibitor (ZPI) in Situ in Human Malignant Tumors |
| Jr.9 |
- |
The Influence of Previous or Currently Active Cancer on Venous Thromboembolism Prophylaxis Prescribing Practices in Acutely Ill Medical Patients |
| Jr1 |
- |
Identification of Gene Defects in Brazilian Patients with Types 2B, 2M and 3 of von Willebrand Disease |
| Jr2 |
- |
A Monoclonal Antibody to High Molecular Weight Kininogen Reduces Inflammation in the HLA-B27 Transgenic Rat Model of Inflammatory Bowel Disease and Arthritis |
| J[emptyv]rgensen M |
- |
Catheter Directed Thrombolysis of Acute Iliofemoral Deep Venous Thrombosis Is Effective and Preserves Venous Valve Function. Results from a Prospective One-centre Study of 60 Cases |
| Jørgensen M |
- |
Congenital Aplasia of the Inferior Vena Cava Is a Major Risk Factor for Iliofemoral Deep Venous Thrombosis. A Prospective One-centre Study of 50 Cases |
| Ju MY |
- |
IgM Anti-beta2 Glycoprotein I Antibody as Potential Risk Factor of Thrombosis in Patients with Lupus Anticoagulants |
| Jucá AVS |
- |
807C/T Polymorphism in the Platelet Glycoprotein Ia Gene in Patients with Ischemic Stroke (IS) of Undetermined Etiology |
| Jude B |
- |
Plasma Levels of Tissue Factor and von Willebrand Factor Predict Long Term Clinical Outcome after Percutaneous Coronary Revascularization |
| |
- |
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects |
| Judge HM |
- |
Incomplete P2Y12 Receptor Blockade by Clopidogrel Is Not Due to the Presence of an Internal Pool of P2Y12 Receptors |
| Judge HM |
- |
Utility of a Whole-Blood Single-Platelet Counting Assay in Monitoring the Effects of Tirofiban |
| Judge H |
- |
Monitoring of P2Y12 Receptor Antagonist Efficacy |
| Judge HM |
- |
The PAR-1 IVSn-14 A/T Polymorphism Influences TRAP-Induced Platelet Calcium Mobilisation and Platelet Procoagulant Responses |
| Juhan-Vague I |
- |
Role of the Fibrinolytic System in the Development of Obesity and the Metabolic Syndrome |
| Juhan-Vague I |
- |
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects |
| |
- |
Lipopolysaccharide-Induced Endotoxemia in the Mouse is Aggravated by PAI-1 Overexpression |
| |
- |
Low Platelet Response to Clopidogrel Increased the Risk of Recurrent Atherothrombotic Events in Patients with Non-ST Acute Coronary Syndrome after Coronary Stenting |
| |
- |
The TNF Alpha Converting Enzyme (TACE/ADAM17) Is Expressed in the Atherosclerotic Lesion of ApoE-deficient Mice |
| |
- |
TAFI Gene Polymorphisms and Plasma TAFI Levels: A Trans-Ethnic Association Study |
| |
- |
Polymorphism A36G of the Tumor Necrosis Factor Receptor 1 Gene Is Associated with HDL Cholesterol, TNFR1 and PAI-1 Levels in Obese Women |
| Juin F |
- |
Retrospective Study of 41 Patients Homozygous for the Prothrombin G20210A Mutation |
| Julian J |
- |
Proportion of Major Bleeds That Are Intracranial or Fatal According to Indication for Oral Anticoagulant Therapy |
| |
- |
Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH) |
| |
- |
Derivation of a Clinical Model to Predict the Likelihood of Recurrent Deep Vein Thrombosis |
| |
- |
Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial |
| Jun T |
- |
Biological Properties of a Specific Gaq/11 Inhibitor, YM-254890, on Platelet Functions and Thrombus Formation under High-shear Stress |
| Jun M |
- |
Fatal Hemorrhagic Disorder and Vascular Intimal Carcinomatosis in Annexin II Expressing Transitional Cell Carcinoma |
| Jung IS |
- |
Cardioprotective Effect of KR-32568, a Novel Sodium/hydrogen Exchanger-1 Inhibitor, in a Rat Model of Ischemia and Reperfusion Heart Injury |
| Jung SM |
- |
Identification of collagen-Binding Region of Platelet Glycoprotein VI (GPVI): Studies Using GPVI/Killer Cell Inhibitory Receptor Chimeric Proteins |
| Jung SM |
- |
Analyses of the Interaction of Platelet Collagen Receptor Glycoprotein (GP) VI with Various Types of Collagen |
| Jung SM |
- |
The Rap1 Activation Mechanism in Platelets: It is Related to the Release Reaction Mediated Through the Collagen Receptor Glycoprotein (GP) VI |
| Jungbauer A |
- |
Combinatorial Peptides Directed to Inhibitory Antibodies against Human Blood Clotting Factor VIII |
| Junji N |
- |
Diagnosis of Deep Vein Thrombosis by Soluble Fibrin or D-dimer |
| Junqueira-de-Azevedo ILM |
- |
Amblyomma Cajennense Tick: The Transcriptome, Expression and Biochemical Characterization of a Factor Xa Recombinant Inhibitor |
| |
- |
Identification of New Secreted Proteins from Haementeria Depressa Leech Salivary Complexes by Transcriptomic and Proteomic Analysis |
| Jünschke A |
- |
INR Results of the CoaguChek® PT Test Compare Well with INR Results of International Reference Thromboplastins |
| Jurk K |
- |
Severe Bleeding Caused by a Platelet Defect Leading to Enhanced Binding of Coagulation Factor XI (FXI) to Platelet GPIb-alpha |
| Jurk K |
- |
Albumin Mildly Oxidized by the Myeloperoxidase Product Hypochlorous Acid Strongly Activates Platelets and Monocytes Via CD36 |
| |
- |
New Function for Protease Inhibitors Alpha1 Antitrypsin and Antithrombin III Inhibit the Activation of Platelets by Alpha Defensins from Neutrophils |
| |
- |
Prothrombotic Tendency upon Inflammatory Conditions Alpha Defensins (HNP-1/2/3) Are Strong Platelet Agonists |
| |
- |
Platelet Activation Markers and Procoagulant Phenotype of Monocytes do Correlate with Markers of Reperfusion Injury Following Reperfusion after Orthotopic Liver Transplantation |
| Jürs M |
- |
Heparin Abrogates the Positive Effect of High-dose Antithrombin III in Severe Sepsis (KyberSept Study) |
| Just O |
- |
A Comparison of Two Manufacturing Processes for an Antithrombin Concentrate |
| Just S |
- |
Post Varicella Purpura Fulminans Treatment with Activated Protein C Concentrate |
| Just M |
- |
Otamixaban, a Direct Factor Xa Inhibitor, More Potently Inhibits Experimental Coronary Thrombosis than Bivalirudin, a Direct Thrombin Inhibitor |
| Just S |
- |
Queensland Health Pathology Service Statewide Coagulation Quality Control Database: the First Three Years Experience |
| Just S |
- |
The PFA 100: Platelet Function ScreeningThe Queensland Health Pathology Service (Q.H.P.S.) Experience |
| |
- |
Comparison of the Effectiveness of Protamine Sulphate and Polybrene in Neutralising Heparin in Patient Samples for Laboratory Testing |
| Just S |
- |
Catheter Directed Thrombolysis of Acute Iliofemoral Deep Venous Thrombosis Is Effective and Preserves Venous Valve Function. Results from a Prospective One-centre Study of 60 Cases |
| Just M |
- |
The New Anticoagulant Octaparin Displays High Antithrombotic Action in Venous Thrombosis in Rabbits and Rats without Impairment of Hemostasis |
| Justice MJ |
- |
Abnormal Megakaryocyte Maturation, Abortive Platelet Shedding and inflammatory Disease Caused By Mutations in the Cytoskeletal Regulator Aip1 |
| Juszynski A |
- |
Severe Hemophilia in Poland Focus on Hemophilic Arthropathy |
| Jy W |
- |
ITP Developing in Spouses of Patients with Chronic ITP: Spousal ITP |
| |
- |
Antiphospholipid Antibodies and Platelet Activation as Thrombotic Risk Factors in Thrombocythemia Associated with Myeloproliferative Disorder |
| |
- |
Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions |